- Home
- BWG vs MYO Comparison
BWG vs MYO Comparison
Compare BWG & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWG
- MYO
- Stock Information
- Founded
- BWG 2012
- MYO 2004
- Country
- BWG United States
- MYO United States
- Employees
- BWG N/A
- MYO N/A
- Industry
- BWG Finance/Investors Services
- MYO Industrial Specialties
- Sector
- BWG Finance
- MYO Health Care
- Exchange
- BWG Nasdaq
- MYO Nasdaq
- Market Cap
- BWG 142.1M
- MYO 157.9M
- IPO Year
- BWG N/A
- MYO 2017
- Fundamental
- Price
- BWG $8.21
- MYO $5.99
- Analyst Decision
- BWG
- MYO Strong Buy
- Analyst Count
- BWG 0
- MYO 4
- Target Price
- BWG N/A
- MYO $8.25
- AVG Volume (30 Days)
- BWG 53.8K
- MYO 400.7K
- Earning Date
- BWG 01-01-0001
- MYO 03-06-2025
- Dividend Yield
- BWG 11.37%
- MYO N/A
- EPS Growth
- BWG N/A
- MYO N/A
- EPS
- BWG N/A
- MYO N/A
- Revenue
- BWG N/A
- MYO $25,239,125.00
- Revenue This Year
- BWG N/A
- MYO $59.01
- Revenue Next Year
- BWG N/A
- MYO $40.60
- P/E Ratio
- BWG N/A
- MYO N/A
- Revenue Growth
- BWG N/A
- MYO 36.23
- 52 Week Low
- BWG $6.86
- MYO $2.51
- 52 Week High
- BWG $8.65
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- BWG 52.88
- MYO 46.67
- Support Level
- BWG $7.90
- MYO $5.83
- Resistance Level
- BWG $8.32
- MYO $6.31
- Average True Range (ATR)
- BWG 0.11
- MYO 0.39
- MACD
- BWG 0.04
- MYO -0.11
- Stochastic Oscillator
- BWG 73.81
- MYO 11.94
About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in global fixed-income securities.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).